Vanda Pharmaceuticals
VNDA
#8812
Rank
S$0.26 B
Marketcap
S$4.44
Share price
-6.13%
Change (1 day)
-33.87%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2026 (TTM): -S$0.23 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are S$0.22 Billion. In 2025 the company made an earning of -S$0.2 Billion a decrease over its 2024 earnings that were of -S$52.46 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$0.23 Billion17.41%
2025 -S$0.2 Billion271.79%
2024 -S$52.46 Million191.43%
2023 -S$18 Million-320.45%
2022 S$8.16 M-84.99%
2021 S$54.39 M54.8%
2020 S$35.13 M19.42%
2019 S$29.42 M4.93%
2018 S$28.04 M-228.6%
2017 -S$21.81 Million-8.98%
2016 -S$23.96 Million-53.79%
2015 -S$51.84 Million-30.18%
2014 -S$74.25 Million173.08%
2013 -S$27.19 Million-25.33%
2012 -S$36.42 Million163.61%
2011 -S$13.82 Million-221.15%
2010 S$11.4 M-124.53%
2009 -S$46.49 Million-29.44%
2008 -S$65.88 Million-36.2%
2007 -S$0.11 Billion21.81%
2006 -S$84.77 Million170.55%
2005 -S$31.33 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$24.15 B-10,622.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$16.30 B-7,206.52%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$8.98 B-4,016.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$44.85 B-19,643.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$8.67 B-3,878.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$14.61 B-6,469.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-S$3.62 Million-98.42%๐Ÿ‡บ๐Ÿ‡ธ USA